摘要
目的:观察依托必利联合阿米替林治疗功能性消化不良的临床疗效。方法:将98例功能性消化不良患者随机1:1分为对照组和治疗组,对照组给予依托必利(50mg,tid,饭前15~30min服用)治疗,治疗组在对照组的基础上加用阿米替林(25mg,bid),比较2组的临床疗效及不良反应发生情况。结果:治疗组治愈32例,有效10例,无效7例,总有效率为85.7%;对照组治愈23例,有效12例,无效14例,总有效率为71.4%。2组总有效率比较,差异有统计学意义(P<0.01)。治疗组不良反应总发生率为46.9%,对照组为44.9%,2组比较差异无统计学意义(P>0.05)。结论:依托必利联合阿米替林治疗功能性消化不良效果较好,不良反应轻微。
OBJECTIVE:To explore the comprehensive effect of itopride combined with amitriptyline in the treatment of functional dyspepsia.METHODS:98 patients with functional dyspepsia were randomly divided into treatment group and control group.Control group was treated with itopride(50 mg,tid,15~30 min a.c.).On the basis of itopride,treatment group was additionally treated with amitriptyline(25 mg,bid).Clinical efficacy and adverse drug reactions were compared between 2 groups.RESULTS:In treatment group,32 cases were cured,10 cases were effective,7 cases were failure,total effective rate was 85.7%.In control group,23 cases were cured,12 cases were effective,14 cases were failure,total effective rate was 71.4%.There was significant difference in total effective rate between 2 groups(P0.01).The therapeutic efficacy of treatment group was better than that of control group.The total incidence of adverse drug reactions was 46.9% for treatment group and 44.9% for control group.There was no significant difference between 2 groups(P0.05).CONCLUSION:Itopride combined with amitriptyline is good for the treatment of functional dyspepsia without serious adverse drug reactions.
出处
《中国药房》
CAS
CSCD
北大核心
2011年第36期3398-3399,共2页
China Pharmacy